By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arrowhead Pharmaceuticals (Formerly Known As Arrowhead Research Corporation) 

1118 East Green Street

Pasadena  California  91106  U.S.A.
Phone: 626-792-5549 Fax: 626-792-5554


Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.

Key Statistics

Ownership: Public

Web Site: Arrowhead Pharma
Symbol: ARWR

Medical Device

Company News
Floundering SoCal Biotech Arrowhead Pharma (ARWR) Fires CSO, Effective Later This Month 12/2/2016 5:53:22 AM
SoCal's Arrowhead Pharma (ARWR) Stock Craters After Terminating 30% of Workforce, Discontinuing Work on Lead Hep B Drugs 11/30/2016 5:40:03 AM
Arrowhead Pharma (ARWR) Announces Closing Of License And Collaboration Agreement With Amgen (AMGN) 11/21/2016 11:00:10 AM
Arrowhead Pharma (ARWR) Presents New Data On ARC-F12 And ARC-LPA Using DPCsqTM Subcutaneous RNAi Delivery Vehicle 11/15/2016 10:47:15 AM
Arrowhead Pharma (ARWR) Presents New Data On ARC-AAT 11/14/2016 11:16:29 AM
FDA Slaps Clinical Hold on Arrowhead Pharma (ARWR)'s Hep B Study 11/9/2016 5:52:32 AM
Arrowhead Pharma (ARWR) To Present Data On ARC-AAT At The Liver Meeting 10/20/2016 11:52:38 AM
Arrowhead Pharma (ARWR) And Spring Bank Pharmaceuticals, Inc. Announce Clinical Collaboration For ARC-520 And SB 9200 In Chronic Hepatitis B 10/6/2016 11:14:00 AM
How Ionis Pharma (IONS) is Beating the Pants Off of Competitors Like Alnylam (ALNY), Arrowhead Pharma (ARWR) and Moderna 9/20/2016 6:51:59 AM
Arrowhead Pharma (ARWR) Doses First Patient With Hepatitis B In Multiple Ascending Dose Portion Of Phase I/II Study Of ARC-521 9/7/2016 1:06:30 PM